MedPath

Intrathecal Morphine for Radical Robot Assisted Prostatectomy (TORNADO)

Not Applicable
Completed
Conditions
Catheter Related Complication
Interventions
Drug: intrathecal infusion
Drug: Intravenous Infusion
Registration Number
NCT04814745
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

investigators aim to compare the efficacy of intrathecal morphine, intravenous tramadol and transversus abdominis plane block in the treatment of catheter related bladder discomfort syndrome in patients scheduled for robotic assisted laparoscopic prostatectomy

Detailed Description

patients scheduled for robot assisted laparoscopic prostatectomy will be treated depending on the belonging group. In the morphine group patients will receive intrathecal morphine 0,15 mg; in the transversus abdominis plane block patients will receive ropivacaine 80 mg; in the tramadol group patients will receive intravenous continuous infusion of tramadol 400 mg for the first 24 hours postoperatively. All data will be collected in the post anesthesia room and in the ward until the first post operative day.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
33
Inclusion Criteria
  • all patients scheduled for robotic assisted laparoscopic prostatectomy
Exclusion Criteria
  • coagulation disorders and platelet dysfunction for spinal arm
  • obesity for transversus abdominis plane block arm
  • left ventricular ejection fraction < 30%, end-stage renal disease and neurological disorders for all groups

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
morphineintrathecal infusionmorphine 150 mcg will be administered intrathecally before surgery by using a 25 Gauge with acre spinal needle
tramadolIntravenous Infusiontramadol 400 mg will be administered by using an elastomeric pump for 24 hours after surgery
ropivacaineRopivacaine injectionat the end of surgery transversus abdominis plane block will be performed bilaterally and ropivacaine 80 mg will be used
Primary Outcome Measures
NameTimeMethod
catheter related bladder discomfort syndromeimmediately after surgery

grade 0 to III

Secondary Outcome Measures
NameTimeMethod
pain reliefimmediately after surgery

assessment of post-operative pain by a 0 to 10 numeric rating score

Trial Locations

Locations (1)

Andrea

🇮🇹

Roma, Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath